Smoking exposure in early pregnancy and adverse pregnancy outcomes: Usefulness of urinary tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol levels
Gynecologic and Obstetric Investigation May 24, 2018
Lee SW, et al. - Researchers sought to determine the effect of maternal smoking exposure assessed by urinary tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-a1-butanol (NNAL) with adverse pregnancy outcomes. Findings suggested the utility of urinary NNAL as a biomarker for detecting maternal smoking status in association with adverse pregnancy outcomes. In preconception and pregnancy counseling before planning pregnancy, using this marker might allow prevention of several adverse pregnancy outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries